The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest

被引:347
作者
Jonard, S [1 ]
Dewailly, D [1 ]
机构
[1] CHRU, Hop Jeanne Flandre, Dept Endocrine Gynaecol & Reprod Med, F-59037 Lille, France
关键词
anti-Mullerian hormone; androgens; follicular arrest; folliculogenesis; polycystic ovary syndrome;
D O I
10.1093/humupd/dmh010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This review exposes the follicular abnormalities responsible for anovulation in polycystic ovary syndrome (PCOS). The putative pathophysiological explanations involve the principal intra- and extra-ovarian regulators which intervene during normal folliculogenesis to control the initial recruitment and growth and then the cyclic recruitment. We propose the hypothesis that the follicular problem in PCOS is 2-fold, but with the two abnormalities being linked. First, the intra-ovarian hyperandrogenism may promote early follicular growth, leading to a 2-5 mm follicle excess. Second, the ensuing excessive number of selectable follicles would inhibit the selection process, presumably through follicle-follicle interaction involving granulosa cell (GC) products such as the anti-Mullerian hormone (AMH). These factors would induce a reversible refractoriness to the FSH-induced differentiation of GC. This explanation challenges but does not exclude other hypotheses about the follicular arrest, such as the premature LH action on the GC of selectable follicles. Hyperinsulinism or insulin resistance would act as a second hit, worsening the follicular arrest either through amplification of the intra-ovarian hyperandrogenism or through dysregulation of the GC. The loss of cyclic rhythm would prevent the inter-cycle elevation of FSH, thus perpetuating the impairment of the ovulation process.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 119 条
[11]   Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome [J].
Coffler, MS ;
Patel, K ;
Dahan, MH ;
Malcom, PJ ;
Kawashima, T ;
Deutsch, R ;
Chang, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1742-1747
[12]   Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women [J].
Cook, CL ;
Siow, Y ;
Brenner, AG ;
Fallat, ME .
FERTILITY AND STERILITY, 2002, 77 (01) :141-146
[13]   Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome [J].
Cortet-Rudelli, C ;
Pigny, P ;
Decanter, C ;
Leroy, M ;
Maunoury-Lefebvre, C ;
Thomas-Desrousseaux, P ;
Dewailly, D .
FERTILITY AND STERILITY, 2002, 77 (02) :281-287
[14]   A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome [J].
Costello, MF ;
Eden, JA .
FERTILITY AND STERILITY, 2003, 79 (01) :1-13
[15]  
DAHLGREN E, 1992, FERTIL STERIL, V57, P505
[16]   ANDROGENS IN THE OVARIAN MICROENVIRONMENT [J].
DANIEL, SAJ ;
ARMSTRONG, DT .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1986, 4 (02) :89-100
[17]  
Dewailly D, 2003, HUM REPROD, V18, P42
[18]  
Dewailly D., 2003, OXFORD TXB ENDOCRINO, P1135
[19]  
DICLEMENTE N, 1992, DEVELOPMENT, V114, P721
[20]  
Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO